SODIUM OZAGREL, A THROMBOXANE SYNTHETASE INHIBITOR, PREVENTS ACUTE REOCCLUSION AND RESTENOSIS FOLLOWING PRIMARY ANGIOPLASTY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
J. Kato et al., SODIUM OZAGREL, A THROMBOXANE SYNTHETASE INHIBITOR, PREVENTS ACUTE REOCCLUSION AND RESTENOSIS FOLLOWING PRIMARY ANGIOPLASTY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 29(2), 1997, pp. 94710-94710